BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16202916)

  • 1. Inaccuracy of coagulation studies performed on blood samples obtained from arterial catheter.
    Akinci SB; Salman N; Aykut T; Kanbak M; Aypar U
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):702-3. PubMed ID: 16202916
    [No Abstract]   [Full Text] [Related]  

  • 2. Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery: a comparative study.
    Leyvi G; Zhuravlev I; Inyang A; Vinluan J; Ramachandran S; Lehning EJ; Wasnick JD
    J Cardiothorac Vasc Anesth; 2004 Oct; 18(5):573-80. PubMed ID: 15578467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protamine dosing--the quandary continues.
    Hall RI
    Can J Anaesth; 1998 Jan; 45(1):1-5. PubMed ID: 9466018
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of heparin-coated pulmonary artery catheters on activated coagulation time in cardiac surgical patients.
    Haering JM; Maslow AD; Parker RA; Lowenstein E; Comunale ME
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):260-3. PubMed ID: 10890477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiopulmonary bypass and blood coagulation].
    Kitaguchi K; Furuie H
    Masui; 2001 Dec; 50 Suppl():S115-20. PubMed ID: 11871083
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk management in cardiac anesthesia: analysis of critical issues. Introduction.
    Ellison N; Pierce EC
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):1-2. PubMed ID: 9583567
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activated coagulation time during surgery with extracorporeal circulation].
    Piatnitskaia GKh; Khodaz MIa; Savina ME; Dement'eva II
    Anesteziol Reanimatol; 1991; (5):66-74. PubMed ID: 1767969
    [No Abstract]   [Full Text] [Related]  

  • 10. Low heparinization and heparin-bonded circuits.
    Hill RC
    Ann Thorac Surg; 1997 Oct; 64(4):1221-2. PubMed ID: 9354574
    [No Abstract]   [Full Text] [Related]  

  • 11. Con: Heparin-bonded cardiopulmonary bypass circuits should be routine for all cardiac surgical procedures.
    Taneja R; Cheng DC
    Anesth Analg; 2006 Dec; 103(6):1370-2. PubMed ID: 17122205
    [No Abstract]   [Full Text] [Related]  

  • 12. More biocompatibility in cardiopulmonary bypass for high-risk patients.
    Baufreton C
    Ann Thorac Surg; 2006 Feb; 81(2):790-1; author reply 791. PubMed ID: 16427917
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does preoperative level of antithrombin III predict heparin resistance during extracorporeal circulation?
    Rodríguez-López JM; del Barrio E; Lozano FS; Muriel C
    Anesth Analg; 2008 Oct; 107(4):1444-5. PubMed ID: 18806070
    [No Abstract]   [Full Text] [Related]  

  • 16. Pro: Is the pulmonary artery catheter dead?
    Ramsay J
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):144-6. PubMed ID: 17289498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin resistance associated with elevated factor VIII].
    Kumano N; Ikeda S; Arimori Y; Ono T; Saeki S
    Masui; 2008 Apr; 57(4):471-3. PubMed ID: 18416208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another bleeding heart: perioperative heparin management revisited.
    Harle CC; Murkin JM
    Can J Anaesth; 2007 Feb; 54(2):97-102. PubMed ID: 17272247
    [No Abstract]   [Full Text] [Related]  

  • 19. Con: Is the pulmonary artery catheter dead?
    Murphy GS; Vender JS
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):147-9. PubMed ID: 17289499
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiopulmonary support in the intensive care unit.
    Pritchard GL
    Am J Crit Care; 1993 Jan; 2(1):100-1. PubMed ID: 8353573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.